Загрузка...
YKL-40 genetic polymorphisms and the risk of liver disease progression in patients with advanced fibrosis due to chronic hepatitis C
BACKGROUND/AIMS: The aim of this study was to explore the association of a functional YKL-40 promoter polymorphism (rs4950928) with baseline disease stage, response to antiviral therapy, and risk of liver disease progression in a group of patients with chronic hepatitis C (CHC). METHODS: YKL-40 prom...
Сохранить в:
| Главные авторы: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2011
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3299849/ https://ncbi.nlm.nih.gov/pubmed/22103814 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1478-3231.2011.02686.x |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|